Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

References

• HalpernNAGoldmanDATanKSPastoresSMTrends in critical care beds and use among population groups and Medicare and Medicaid beneficiaries in the United States: 2000–2010Crit Care Med20164481490149927136721
   PubMed Web of Science ®Google Scholar
• LaiCCHoCHChangCLCritical care medicine in Taiwan from 1997 to 2013 under national health insuranceJ Thorac Dis20181084957496530233870
   PubMed Web of Science ®Google Scholar
• Navoa-NgJABerbaRGalapiaYADevice-associated infections rates in adult, pediatric, and neonatal intensive care units of hospitals in the Philippines: international nosocomial infection control Consortium (INICC) findingsAm J Infect Control201139754855421616564
   PubMed Web of Science ®Google Scholar
• TaoLHuBRosenthalVDGaoXHeLDevice-associated infection rates in 398 intensive care units in Shanghai, China: international nosocomial infection control Consortium (INICC) findingsInt J Infect Dis20111511e774e78021846591
   PubMed Web of Science ®Google Scholar
• JeanSSHsuehPRLeeWSCarbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important gram-negative bacteria isolated from intensive care units in Taiwan: results from the surveillance of multicentre antimicrobial resistance in Taiwan (SMART) in 2009Int J Antimicrob Agents201341545746223507415
   PubMed Web of Science ®Google Scholar
• JeanSSLeeWSYuKWRates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the surveillance of multicenter antimicrobial resistance in Taiwan (SMART)J Microbiol Immunol Infect201649696997625661253
   PubMedGoogle Scholar
• LeeYLChenYSTohHSAntimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the study for monitoring antimicrobial resistance trends (SMART) from 2006 to 2010Int J Antimicrob Agents201240SupplS29S3622749056
   PubMed Web of Science ®Google Scholar
• TsaoLHHsinCYLiuHYRisk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosaJ Microbiol Immunol Infect201851335936628988663
   PubMedGoogle Scholar
• ChenCHKuoHYHsuPJClonal spread of carbapenem-resistant Acinetobacter baumannii across a community hospital and its affiliated long-term care facilities: A cross sectional studyJ Microbiol Immunol Infect201851337738428826855
   PubMedGoogle Scholar
• LeeCMLaiCCChiangHTPresence of multidrug-resistant organisms in the residents and environments of long-term care facilities in TaiwanJ Microbiol Immunol Infect201750213314428373038
   PubMedGoogle Scholar
• LiuYYWangYWalshTREmergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyLancet Infect Dis201616216116826603172
   PubMed Web of Science ®Google Scholar
• Rodríguez-BañoJGutiérrez-GutiérrezBMachucaIPascualATreatment of infections caused by extended-spectrum-beta-lLactamase-, AmpC-, and carbapenemase-producing EnterobacteriaceaeClin Microbiol Rev2018312e000791729444952
   PubMed Web of Science ®Google Scholar
• CanFMenekseSIspirPImpact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infectionJ Antimicrob Chemother20187351235124129415120
   PubMed Web of Science ®Google Scholar
• RipabelliGTamburroMGuerrizioGTracking multidrug-resistant Klebsiella pneumoniae from an Italian hospital: molecular epidemiology and surveillance by PFGE, RAPD and PCR-Based resistance genes prevalenceNat Microbiol2018758977987
   Google Scholar
• ShenYZhouHXuJAnthropogenic and environmental factors associated with high incidence of mcr-1 carriage in humans across ChinaNat Microbiol2018391054106230038311
   PubMed Web of Science ®Google Scholar
• HungMNHsuehPRChangHTIn vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme dataInt J Antimicrob Agents200729214515216815690
   PubMed Web of Science ®Google Scholar
• JeanSSHsuehPRLeeWSNationwide surveillance of antimicrobial resistance among non-fermentative gram-negative bacteria in intensive care units in Taiwan: SMART programme data 2005Int J Antimicrob Agents200933326627119091522
   PubMed Web of Science ®Google Scholar
• JeanSSHsuehPRLeeWSIn vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: nationwide data from the SMART programmeEur J Clin Microbiol Infect Dis201029447147520108018
   PubMed Web of Science ®Google Scholar
• JeanSSLeeWSBaiKJRelationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the surveillance of multicenter antimicrobial resistance in Taiwan (SMART) in 2007J Microbiol Immunol Infect2015481859123973410
   PubMedGoogle Scholar
• Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Susceptibility Testing. 28th Informational SupplementM100ED28Wayne, PACLSI2018
   Google Scholar
• RebeloARBortolaiaVKjeldgaardJSMultiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposesEuro Surveill2018236
   PubMedGoogle Scholar
• LaiCCLinYTLinYTClinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harboring Enterobacteriaceae in humans and pigs in TaiwanInt J Antimicrob Agents201852565165730145246
   PubMed Web of Science ®Google Scholar
• QuanJLiXChenYPrevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal studyLancet Infect Dis201717440041028139430
   PubMed Web of Science ®Google Scholar
• WangYTianGBZhangRPrevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical studyLancet Infect Dis201717439039928139431
   PubMed Web of Science ®Google Scholar
• KocsisBKádárBTóthÁkosFullárASzabóDMgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258J Microbiol Immunol Infect201750573573627553451
   PubMedGoogle Scholar
• CorbellaMMarianiBFerrariCThree cases of mcr-1-positive colistin-resistant Escherichia coli bloodstream infections in Italy, August 2016 to January 2017Euro Surveill201722163051728449732
   PubMedGoogle Scholar
• NordmannPLienhardRKiefferNClercOPoirelLPlasmid-Mediated Colistin-Resistant Escherichia coli in Bacteremia in SwitzerlandClin Infect Dis201662101322132326936673
   PubMed Web of Science ®Google Scholar
• Lo-Ten-FoeJRde SmetAMDiederenBMKluytmansJAvan KeulenPHComparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strainsAntimicrob Agents Chemother200751103726373017646414
   PubMed Web of Science ®Google Scholar
• SaderHSFarrellDJFlammRKJonesRNAntimicrobial susceptibility of gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011)Diagn Microbiol Infect Dis201478444344824492025
   PubMed Web of Science ®Google Scholar
• ChangYYChuangYCSiuLKClinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in TaiwanJ Microbiol Immunol Infect201548221922525074627
   PubMedGoogle Scholar